Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, announced today that it has received a $500,000 grant award from the Gates Foundation. This funding will support the deployment of Ceres’ wastewater biosecurity products to global health testing sites across Africa and India.
Global biosecurity has become a top priority, and wastewater surveillance for pathogens in low- and middle-income countries (LMICs) is crucial for pandemic preparedness and prevention. There is a significant need for standardized, low-cost, and easy-to-use wastewater sample processing methods across diverse geographic locations.
This funding will focus on establishing a sustainable supply chain for wastewater testing tools, ensuring that LMICs can continue to monitor priority pathogens beyond the life of the grant. By lowering barriers to adoption, Ceres aims to strengthen national disease surveillance systems and accelerate progress towards global health security.
“Global biosecurity has become a top priority, and wastewater surveillance is one of the most effective ways to monitor pathogens of concern at the population level,” said Ross Dunlap, CEO of Ceres Nanosciences. “By deploying our sample processing products to sites across Africa and India, we can help public agencies act faster, respond to outbreaks earlier, and build resilient surveillance systems that protect millions of lives. We are grateful to the Gates Foundation for supporting this critical need.”
Read more here.